Ting Chang
About
In The Last Decade
Ting Chang
23 papers receiving 604 citations
Hit Papers
Peers
Comparison fields: 5 of 51
- Cardiology and Cardiovascular Medicine 222
- Surgery 209
- Endocrinology, Diabetes and Metabolism 174
- Hepatology 170
- Epidemiology 168
Countries citing papers authored by Ting Chang
This map shows the geographic impact of Ting Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ting Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ting Chang more than expected).
Fields of papers citing papers by Ting Chang
This network shows the impact of papers produced by Ting Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ting Chang. The network helps show where Ting Chang may publish in the future.
Co-authorship network of co-authors of Ting Chang
This figure shows the co-authorship network connecting the top 25 collaborators of Ting Chang. A scholar is included among the top collaborators of Ting Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ting Chang. Ting Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia breakdown → | 103 |
| 4 | Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia breakdown → | 103 |
| 5 | 2 | |
| 6 | 65 | |
| 7 | 41 | |
| 8 | 6 | |
| 9 | 65 | |
| 10 | 14 | |
| 11 | 34 | |
| 12 | 8 | |
| 13 | 112 | |
| 14 | 8 | |
| 15 | 9 | |
| 16 | 4 | |
| 17 | 4 | |
| 18 | 3 | |
| 19 | 6 | |
| 20 | Immune response to hepatitis B vaccine of subjects with isolated antibody to hepatitis B core antigen. | 7 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.